Analysts Expect Irhythm Technologies Inc (IRTC) to Post ($0.35) EPS

Analysts Expect Irhythm Technologies Inc (IRTC) to Post ($0.35) EPS

Shares of Irhythm Technologies Inc (NASDAQ:IRTC) have been given a consensus broker rating score of 1.13 (Strong Buy) from the four brokers that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a buy rating and three have given a strong buy rating to the company.

Analysts have set a 12 month consensus price target of $34.75 for the company and are expecting that the company will post ($0.35) EPS for the current quarter, according to Zacks. Zacks has also given Irhythm Technologies an industry rank of 184 out of 265 based on the ratings given to related companies.

A number of brokerages have issued reports on IRTC. Zacks Investment Research downgraded Irhythm Technologies from a “hold” rating to a “sell” rating in a research report on Monday, February 20th. BTIG Research downgraded Irhythm Technologies from a “buy” rating to a “neutral” rating in a research report on Tuesday, December 6th.

Shares of Irhythm Technologies (NASDAQ:IRTC) traded up 0.31% on Wednesday, reaching $35.42. The company’s stock had a trading volume of 2,325 shares. The firm has a 50-day moving average price of $35.50 and a 200 day moving average price of $30.43. The firm’s market capitalization is $593.50 million. Irhythm Technologies has a one year low of $22.16 and a one year high of $40.48.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in IRTC. State Street Corp acquired a new position in Irhythm Technologies during the fourth quarter worth approximately $1,916,000. Federated Investors Inc. PA acquired a new position in Irhythm Technologies during the fourth quarter worth approximately $3,000,000. Janus Capital Management LLC acquired a new position in Irhythm Technologies during the fourth quarter worth approximately $3,011,000. Foresite Capital Management III LLC acquired a new position in Irhythm Technologies during the fourth quarter worth approximately $4,986,000. Finally, Board of Trustees of The Leland Stanford Junior University acquired a new position in Irhythm Technologies during the fourth quarter worth approximately $7,599,000. 3.65% of the stock is currently owned by hedge funds and other institutional investors.

Irhythm Technologies Company Profile

iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.

Get a free copy of the Zacks research report on Irhythm Technologies (IRTC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment